You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The New York Times reports that the SARS-CoV-2 strain recently identified in the UK appears to be more easily transmitted, but otherwise is similar to other viral strains.
In PLOS this week: genomic and transcriptomic analysis of conjunctival melanoma, phylogenetic analysis of Clostridioides difficile, and more.
The New York Times reports the first case of the SARS-CoV-2 strain that is suspected to be more infectious has been identified in the US.
The UK's Medicines and Healthcare products Regulatory Authority has approved the SARS-CoV-2 vaccine from Oxford University and AstraZeneca, the Guardian reports.
The Verge reports that the EU-UK trade deal includes a provision that the transfer of DNA profiles rely on outdated email software.
In Cell this week: functional changes in bacteria and yeast due to protein structure alterations, C. elegans NeuroPAL labeling strategy, and more.
ScienceInsider reports that the UK-EU trade deal allows UK researchers access to EU research funding.
Maryland launched a state-wide program to test wastewater for SARS-CoV-2, according to the Washington Post.
The Wall Street Journal reports on an increased push for COVID-19 testing in the US.
In PNAS this week: deep learning-based transcription factor prediction approach, simulation study of the Crabtree effect in yeast, and more.
An analysis appearing in a preprint suggests the SARS-CoV-2 strain identified in the UK may be more easily transmitted, the New York Times reports.
Novavax is launching a late-stage clinical trial of its prospective SARS-CoV-2 vaccine in the US and Mexico, according to the Financial Times.
The Guardian reports that DNA barcoding has fueled the discovery of additional species and has pointed to greater biological diversity.
In PLOS this week: interaction of uracil-N-glycosylase and activation induced deaminase enzymes in B cell lymphoma, E. coli strains linked to bloodstream infections, and more.
The Globe and Mail reports UK researchers say their discovery of a new strain of SARS-CoV-2 highlights the importance of viral genomic surveillance.
Nature News reports on which countries got Horizon 2020 research funding.
Researchers have sequenced the genome of the vanilla plant, which could help boost the quality of vanilla beans, the Miami Herald reports.
In Nucleic Acids Research this week: database of coronavirus gene, pathway, and gene signature data; updates to MethHC database; and more.
The chief executive of BioNTech says the vaccine his company developed with Pfizer should be effective against the new SARS-CoV-2 strain found in the UK, the Guardian reports.
According to Retraction Watch, Nature Communications has retracted a highly criticized article on mentorship.
According to ABC7 News, DNA testing indicates one coyote is responsible for three attacks in the East Bay area.
In PNAS this week: effect of mutagenic compounds on transcription in yeast, role for GATA6 in regulating sinus node development, and more.
The US Food and Drug Administration granted an Emergency Use Authorization for Moderna's SARS-CoV-2 vaccine, the New York Times reports.
The European Medicines Agency has recommended the conditional approval of Pfizer and BioNTech's SARS-CoV-2 vaccine, according to the Associated Press.
Science reports that researchers are working to determine the significance of the SARS-CoV-2 strain identified in the UK.
The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.
According to the Associated Press, a Swiss program aims to shepherd long-term science projects and diplomacy.
CNN reports that two new studies suggest the B.1.1.7 SARS-CoV-2 variant may be more transmissible, but may not lead to more severe disease.
In PNAS this week: analysis of pathway affecting acute kidney injury, parental-specific allelic expression in horse placenta, and more.